While CDKN2A (p16INK4a) is classically recognised as a tumour suppressor that inhibits cyclin‐dependent kinases and induces cell cycle arrest [31], emerging evidence suggests context‐dependent oncogenic functions in certain cancer types [32]. The gene discussed is CDKN2A; the disease is cancer.